{
    "nct_id": "NCT04068649",
    "official_title": "A Phase 2 Randomized Study With a Non-randomized Cohort : Assessing Single-Fraction SBRT Versus Standard Palliative Radiation in Patients With Metastatic Disease (ASTEROID)",
    "inclusion_criteria": "* Pathologically confirmed malignancy\n* Clinical or pathologic evidence of metastatic disease\n* A site of malignant disease causing symptoms, or for which symptoms are imminent, in which radiation may be used for relief or prophylaxis\n* Participants of child-bearing potential must agree to use adequate contraceptive methods (e.g., hormonal or barrier method of birth control; abstinence) prior to study entry. Should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately\n* Participants with synchronous primary malignancies must have either: 1) documented control of their second malignancy or 2) have pathological confirmation of the metastatic lesion/disease site being targeted\n* Participant must be willing and able to participate in protocol requirements, including pre- and post-treatment survey evaluations and clinical assessments\n* Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior radiation therapy targeting the same area for which radiation treatment is being planned (i.e., re-irradiation to a specific site of metastatic disease)\n* Participants with known brain metastases\n* Pregnant or nursing female participants\n* Participants who are unable to accurately or reliably recount their pain medication regimens, including type, amount, or frequency of pain medication usage\n* Participants who require or are being planned for surgical stabilization or metastasectomy of the planned radiation site\n* Severe, active co-morbidity defined as follows:\n\n  * Unstable angina and/or congestive heart failure requiring hospitalization within the last 3 months;\n  * Transmural myocardial infarction within the last 3 months;\n  * Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration;\n  * Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of registration\n* Unwilling or unable to follow protocol requirements\n* Any condition which, in the investigator?s opinion, deems the patient unable to participate in enrollment\n* Adults unable to consent\n* Individuals who are not yet adults (infants, children, teenagers)\n* Pregnant women\n* Prisoners",
    "miscellaneous_criteria": ""
}